by Prostate Cancer Center | Sep 16, 2025 | High Risk Prostate Cancer Treatment
CyberKnife Cure Rates for Non-Metastatic Prostate Cancer: For high-risk prostate cancer, specifically a Gleason score of 8 or 9, CyberKnife—a form of stereotactic body radiation therapy (SBRT)—is considered a viable and effective treatment, typically in combination...
by Prostate Cancer Center | May 8, 2025 | High Risk Prostate Cancer Treatment
More than 40 Clinical Studies Using Accuray Technology, including CyberKnife were presented at the European Society for Radiotherapy and Oncology also known as (ESTRO) That new data presented at the meeting reinforces the benefits of the CyberKnife® System for the...
Recent Comments